Russia Pet Nutraceuticals - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2026-2031)

The russia pet nutraceuticals market size was valued at USD 99.30 million in 2025 and is estimated to grow from USD 107.30 million in 2026 to reach USD 158.40 million by 2031, at a CAGR of 8.20% during the forecast period (2026-2031). This report is Segmented by Sub Product (Milk Bioactives, Omega-3 Fatty Acids, Probiotics, Proteins and Peptides, Vitamins and Minerals, and Other Nutraceuticals), by Pets (Cats, Dogs, and Other Pets), and by Distribution Channel (Convenience Stores, Online Channel, Specialty Stores, Supermarkets/Hypermarkets, and More). The Market Forecasts are Provided in Terms of Value (USD).

Russia Pet Nutraceuticals Market Trends and Insights

Pet Humanization and Premiumization in Companion Animal Care

The Russia pet nutraceuticals market is experiencing growth driven by a more personalized and health-conscious approach to pet ownership, particularly in major Russian cities. According to ZOOINFORM, functional pet food accounted for 34.9% of cat food sales value in 2025, an increase from 33.3% in 2024. This indicates that health-focused spending continues to grow, even as lower-priced categories gain volume. Urban pet owners are increasingly scrutinizing ingredient lists, clinical evidence, and product purposes before purchasing supplements, thereby influencing the product mix in the Russian pet nutraceuticals market. This demand trend is most evident among consumers who already purchase premium pet food, regularly consult veterinarians, and prefer condition-specific products over general supplements. While the humanization of pets in Russia remains concentrated within a smaller, affluent urban demographic compared to Western Europe, this group significantly impacts category trends and pricing. This is driving the market toward formulations targeting immunity, digestion, coat quality, and long-term health maintenance. This shift is prompting companies to emphasize clearer scientific backing, simpler claims, and more targeted product positioning to build trust among premium consumers.

Veterinary-Led Preventive Nutrition Adoption

Veterinarians are the most trusted source for product discovery in the Russian pet nutraceuticals market, particularly for supplements that require detailed explanations and consistent use. According to ZOOINFORM RNC Pharma, sales of animal nutraceuticals through veterinary clinics surpassed RUB 44.5 billion (USD 0.5 billion) across measured categories in 2024. The pharmaceutical-adjacent nutraceutical segment grew 16.9% during the first 11 months of 2025, indicating sustained demand driven by veterinary clinics. A veterinary recommendation often shifts a purchase from discretionary spending to an essential component of ongoing pet care for many owners. This shift increases repeat purchase rates and enables better price realization compared to retail-only discovery. Purina’s FortiFlora, holding a 13% share of the Russian supplement market, demonstrates how strong veterinary placement can directly contribute to brand leadership. Consequently, the Russian pet nutraceuticals market is anticipated to remain closely linked to veterinary education, professional endorsements, and clinic access as preventive care becomes more commonplace.

Premium Price Sensitivity Outside Major Urban Centers

Premium affordability remains a significant constraint on the Russian pet nutraceuticals market, particularly outside Moscow and Saint Petersburg. According to ZooInform's 2025 report, hard discounters experienced 20.2% growth in value and 15.4% growth in volume, indicating that many pet owners are still opting for lower-cost options in the broader market. This trend poses a challenge for nutraceuticals, as they are priced higher than standard supplements and everyday pet care products. In secondary and tertiary cities, while many buyers acknowledge basic pet care needs, they are less inclined to pay for products with functional differentiation. Although the Russian pet nutraceuticals market continues to grow, this dynamic limits the buyer base able to sustain premium price points. Revenue generation is thus concentrated within a smaller, urban-affluent demographic, making the market more vulnerable to fluctuations in city-level household spending. Unless the price gap narrows, broader national penetration will remain below the category's potential.

Other drivers and restraints analyzed in the detailed report include:

• Online Replenishment and Subscription Readiness
• Aging Pet Population and Geriatric Mobility Support Demand
• Regulatory Friction for Functional Claims and Novel Ingredients

Segment Analysis

Vitamins and minerals accounted for 26.4% of the Russia pet nutraceuticals market share in 2025, making them the largest subcategory. They are also projected to grow fastest, with a CAGR of 7.9% through 2031, indicating strong performance across both current market share and future growth potential. This segment's broad relevance across various life stages, health conditions, and breed sizes gives it a larger addressable market than more specialized functional niches. Domestic brands such as VEDA with My Totem, ECOPROM with Unitabs, and FARMAKS with Omega Neo are particularly prominent in this category, as familiarity and accessibility are significant factors in everyday supplementation. Notably, VEDA experienced a 44% growth in natural unit sales during the first three quarters of 2025, demonstrating the growing traction of domestic brands in this segment.

Probiotics and omega-3 fatty acids represent the sub-product groups with the strongest clinical expansion narratives in the Russia pet nutraceuticals market. In 2025, Purina’s FortiFlora captured 13% of the measured supplement market, highlighting the strong demand for gut health solutions, particularly when supported by veterinary recommendations. Omega-3 products are also gaining traction as clinical evidence for their benefits in skin, coat, and joint care continues to grow. In contrast, proteins, peptides, and milk bioactives remain less developed, partly due to limited local availability compared to more established international markets. Additionally, other pet nutraceuticals, including herbal and botanical options, are expanding their presence as companies seek differentiation in an increasingly competitive core segment.

Complete Report Scope:

• By Sub Product
  • Milk Bioactives
  • Omega-3 Fatty Acids
  • Probiotics
  • Proteins and Peptides
  • Vitamins and Minerals
  • Other Pet Nutraceuticals
• By Pets
  • Cats
  • Dogs
  • Other Pets
• By Distribution Channel
  • Convenience Stores
  • Online Channel
  • Specialty Stores
  • Supermarkets and Hypermarkets
  • Veterinary Clinics and Pharmacies

List of Companies Covered in this Report:

• Mars, Incorporated
• Nestle S.A. (Purina)
• Virbac
• Vetoquinol S.A.
• Colgate Palmolive (Hills Pet Nutrition)
• Dechra Pharmaceuticals PLC
• ADM
• Kemin Industries, Inc.
• VEDA
• VAFO Group a.s.
• Alltech
• Clearlake Capital Group, L.P. (Wellness Pet Company, Inc.)
• Farmina Pet Foods
• Pet-Product LLC
• APICENNA

Additional Benefits:

• The market estimate (ME) sheet in Excel format
• 3 months of analyst support